Searched for
TEVA API INDIA
Teva-Allergan deal a booster for Indian companiesTeva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products28 Jul, 2015, 05.51 PM IST- Stock diagnosis: Is Cipla a good buy for investors post Q3?According to analysts, rollout of inhalers in Europe and supplies of esomeprazole (Nexium) to Teva will be key triggers for the stock in co...13 Feb, 2015, 04.34 PM IST
- Ind-Swift in stake sale talks with US companies to raise Rs 200 croreInd-Swift Laboratories is in talks with two leading US based firms for strategic stake sale to mop up Rs 200 crore, said sources.30 Jul, 2014, 12.22 PM IST
- Exports to Europe from Ranbaxy's two plants to remain suspendedExports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, European health regulator EMA sai...09 Apr, 2014, 04.47 PM IST
- EU, UK evaluating FDA findings on Ranbaxy's Toansa facilityDays after US FDA banned import of Ranbaxy products to America from its Toansa plant, health regulators of EU & UK have said they are evalu...29 Jan, 2014, 05.05 PM IST
- Actis to buy 25% in steroids maker Symbiotec Pharmalab for Rs 300 crorePrivate equity fund Actis is looking to purchase more than 25% stake in cortico steroids maker Symbiotec Pharmalab for around $50 million.08 Jul, 2013, 08.33 AM IST
- Pharmaceutical firm Teva API to set up unit in Indore SEZ; to invest 1000 crorePharmaceutical firm Teva API India plans to invest about Rs 1,000 crore over the next five years in setting up of a formulation unit in the...29 Aug, 2012, 10.06 PM IST
- Ranbaxy launches low-cost version of medicine 'Lipitor'The US FDA allowed Ranbaxy to make and sell atorvastatin tablets, the chemical name of Lipitor, ending months of uncertainty.02 Dec, 2011, 02.19 AM IST
- Franklin Templeton PE invests Rs 45 cr in drug-maker Symbiotec PharmalabSymbiotec is engaged in research, development, manufacturing and marketing of research-based active pharmaceutical ingredients for corticos...21 Sep, 2011, 04.03 PM IST
- Drug firms fight with foreign cos over patentsPharma companies are at loggerheads with their foreign counterparts over patent rights. Global pharma giants have been filing cases against...04 Dec, 2008, 01.44 AM IST
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...16 Apr, 2008, 02.00 AM IST
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...29 Jun, 2007, 01.39 AM IST
- Merck buy may give Ranbaxy access to US, Europe marketsRanbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...09 Jan, 2007, 02.14 AM IST
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.09 Jan, 2007, 01.56 AM IST
- Teva exploring prospects in Indian marketThe world’s largest generic drug maker Teva Pharmaceuticals is investigating the Indian market and examining what value proposition it can ...05 Jan, 2007, 02.16 AM IST
- Global pharma cos may pop in buyout pillThe high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...30 Aug, 2006, 02.03 AM IST
- US pharma major Mylan buys Matrix LabsThe generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.29 Aug, 2006, 01.58 AM IST
Load More
